Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells

Acta Biochimica Polonica

Volumn 55, Issue 4, 2008, Pages 673-680

  Wu, Yao Hui ^a   You, Yong ^a   Chen, Zhi Chao ^a   Zou, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute myeloid leukemia; Apoptosis; Chemotherapeutic resistance; ShRNA; Survivin

Indexed keywords

EID: 58149517867     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2008_3026     Document Type: Article

References (21)

1. Adida C, Haioun C, Gaulard P (2000) Prognostic significance of Survivin expression in diffuse large B-cell lymphomas. Blood 96: 1921-1925.
2. Adida C, Recher C, Raffoux E (2000) Expression and prognostic significance of Survivin in de novo acute myeloid leukaemia. Br J Haematol 111: 196-203.
3. Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y (2006) Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 107: 746-756.
4. Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589.
5. Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB (2007) Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109: 2293-2302.
6. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
7. Carter BZ, Milella M, Altieri DC, Andreeff M (2001) Cytokine-regulated expression of Survivin in myeloid leukemia. Blood 97: 2784-2790.
8. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
9. Greiner J, Bullinger L, Guinn BA, Döhner H, Schmitt M (2008) Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells. Clin Cancer Res 14: 7161-7166.
10. Hannon GJ (2002) RNA interference. Nature 418: 244-251.
11. Hannon GJ, Rossi JJ (2004) Unlocking the potential of the human genome with RNA interference. Nature 431: 371-378.
12. Ikeguchi M, Liu J, Kaibara N (2002) Expression of Survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis 7: 23-29.
13. Jakubowska J, Stasiak M, Szulawska A, Bednarek A, Czyz M (2007) Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562. Acta Biochim Polon 54: 839-846.
14. Jing Y, Wang L, Xia L (2001) Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97: 264-269.
15. Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008) Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14: 5000-5005.
16. Norgaard JM, Jensen PD, Bendix K, Clausen N, Palshof T (1999) Relevance of in vitro leukemia cell survival to short- and long-term clinical outcome in AML. Leuk Lymphoma 32: 327-337.
17. Olie RA, Simoes-Wust AP, Baumann B (2000) A novel antisense oligonucleotide targeting Survivin expression induce apoptosis sensitizes lung cancer cells to chemotherapy. Cancer Res 60: 2805-2809.
18. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ (2000) Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma. Gut 46: 645-650.
19. Tamm I, Segall H, Kitada S (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803.
20. Tazzari PL, Tabellini G, Ricci F, Papa V, Bortul R, Chiarini F, Evangelisti C, Martinelli G, Bontadini A, Cocco L, McCubrey JA, Martelli AM (2008) Synergistic proapoptotic activity of recombinant TRAIL plus the akt inhibitor perifosine in acute myelogenous leukemia cells. Cancer Res 68: 9394-9403.
21. Zaffaroni N, Pennati M, Daidone MG (2005) Survivin as a target for new anticancer interventions. J Cell Mol Med 9: 360-372.